Cloprostenol 263 Inj Cattle

Verify with FDA CVM →

151 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
151
Total Reports
24
Deaths Reported
1590.0%
Death Rate

Active Ingredients

Cloprostenol 263 Inj Cattle

Administration Routes

UnknownIntramuscularTopicalSubcutaneousParenteralIntravenousOralRespiratory (Inhalation)

Species Affected

Cattle 74
Unknown 44
Human 17
Horse 8
Sheep 3
Pig 1
Goat 1
Donkey 1
Other 1
Other Equids 1

Most Affected Breeds

Unknown 62
Cattle (other) 33
Holstein-Friesian also known as Holstein 12
Aberdeen Angus 11
Cattle (unspecified) 6
Crossbred Bovine/Cattle 6
Horse (unknown) 4
Red Angus 2
Mixed (Horse) 2
Commercial hybrid 1

Most Reported Reactions

Lack of efficacy - NOS 25
INEFFECTIVE, ESTRUS SYNCHRONIZ 23
Death 23
INEFFECTIVE, ESTRUS INDUCTION 16
Closure, Abnormal 16
Hyperextension 11
Uncoded sign 10
Accidental exposure 10
Product problem 9
Seal, Abnormal 8
Caps, Abnormal 8
Stopper, abnormal 8

Outcome Breakdown

Outcome Unknown
58 (43.9%)
Recovered/Normal
32 (24.2%)
Died
24 (18.2%)
Ongoing
18 (13.6%)

Data Summary

Metric Value
Total adverse event reports 151
Reports involving death 24
Case-fatality rate (reported events) 1590.0%
Distinct species in reports 10
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Cloprostenol 263 Inj Cattle Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 151 adverse event reports referencing Cloprostenol 263 Inj Cattle, including 24 reports in which the animal died — a 1590.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Cloprostenol 263 Inj Cattle. Reported administration routes include Unknown, Intramuscular, Topical, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Cloprostenol 263 Inj Cattle reports are Cattle (74 reports), Unknown (44 reports), Human (17 reports), with Cattle accounting for the largest share. Within those species, Unknown (62), Cattle (other) (33), Holstein-Friesian also known as Holstein (12) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Cloprostenol 263 Inj Cattle are Lack of efficacy - NOS (25), INEFFECTIVE, ESTRUS SYNCHRONIZ (23), Death (23), INEFFECTIVE, ESTRUS INDUCTION (16). Of the 132 reports with a coded outcome, Outcome Unknown is the leading category at 43.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Cloprostenol 263 Inj Cattle.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial